[go: up one dir, main page]

IN2009CN03566A - - Google Patents

Download PDF

Info

Publication number
IN2009CN03566A
IN2009CN03566A IN3566CHN2009A IN2009CN03566A IN 2009CN03566 A IN2009CN03566 A IN 2009CN03566A IN 3566CHN2009 A IN3566CHN2009 A IN 3566CHN2009A IN 2009CN03566 A IN2009CN03566 A IN 2009CN03566A
Authority
IN
India
Prior art keywords
compounds
methods
preparing
relates
bompositions
Prior art date
Application number
Other languages
English (en)
Inventor
Josephus H M Lange
Cornelis G Kruse
Belal Shadid
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Priority claimed from PCT/EP2007/064169 external-priority patent/WO2008074816A1/en
Publication of IN2009CN03566A publication Critical patent/IN2009CN03566A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN3566CHN2009 2006-12-20 2007-12-19 IN2009CN03566A (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06126584 2006-12-20
PCT/EP2007/064169 WO2008074816A1 (en) 2006-12-20 2007-12-19 Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition

Publications (1)

Publication Number Publication Date
IN2009CN03566A true IN2009CN03566A (xx) 2015-08-07

Family

ID=38024247

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3566CHN2009 IN2009CN03566A (xx) 2006-12-20 2007-12-19

Country Status (7)

Country Link
CN (1) CN101848907A (xx)
AR (1) AR064379A1 (xx)
BR (1) BRPI0721060A2 (xx)
IN (1) IN2009CN03566A (xx)
MX (1) MX2009006889A (xx)
TW (1) TW200843772A (xx)
ZA (1) ZA200903779B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116033836B (zh) * 2020-07-14 2024-10-18 利斯库生物科学有限公司 包含意外片球菌或来源于其的细胞外囊泡作为有效成分的用于治疗脑部疾病的组合物
CN113880899B (zh) * 2020-10-30 2023-06-23 杭州拉林智能科技有限公司 黄酮苷-有机胺类神经激动剂复盐化合物及其制备方法和应用

Also Published As

Publication number Publication date
MX2009006889A (es) 2009-07-07
CN101848907A (zh) 2010-09-29
BRPI0721060A2 (pt) 2014-02-25
TW200843772A (en) 2008-11-16
AR064379A1 (es) 2009-04-01
ZA200903779B (en) 2010-04-28

Similar Documents

Publication Publication Date Title
IL198926A0 (en) Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition
TW200745135A (en) Therapeutic agents
UA94660C2 (xx) Аміно-гетероциклічні сполуки$амино-гетероциклические соединения
MX336966B (es) Novedosos derivados y su uso en el tratamiento de transtornos neurologicos.
RS20060129A (xx) /1,8/naftiridin-2-oni i srodna jedinjenja za lečenje šizofrenije
MXPA06011194A (es) Tiadiazolidinonas como inhibidores de gsk-3.
TW200531689A (en) Therapeutic agents
ATE455763T1 (de) Piperidine und verwandte verbindungen zur behandlung von alzheimer-krankheit
UA101393C2 (ru) КОМПОЗИЦИИ И ПРИМЕНЕНИЕ ПРОИЗВОДНЫХ ТРИАЗОЛА ДЛЯ ЛЕЧЕНИЯ β-АМИЛОИДОЗОВ И СИНУКЛЕИНОПАТИЙ
TW200630374A (en) Thiazolyldihydroindazoles
UA100232C2 (uk) Кристалічні форми інгібітора glyt1
MX2009005509A (es) 2-aminoquinolina como los antagonistas de los receptores 5-hidroxitriptamina 5a (5-ht5a).
TW200633957A (en) Compounds
TW200714282A (en) Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
MX2009012525A (es) Pirazol-pirrolidinas como inhibidores de gamma secretasa.
TW200734324A (en) Therapeutic agents
TW200635589A (en) Therapeutic agents
GB0428232D0 (en) Compounds
IN2009CN03566A (xx)
MX2009007405A (es) Compuestos con una combinacion de antagonismo de cb1 cannabinoide e inhibicion de recaptacion de serotonina.
WO2008092877A3 (en) 8-oxa-1, 4-diazaspiro [4,5] dec-3-en-1-yl and 1,4, 8-triazaspiro [4,5] dec- 3-en-1-yl acetamides as glyti transporter inhibitors in treatment of neurological and neuropsychiatric disorders
RS20080139A (xx) Jedinjenja imidazola za lečenje neuroloških poremećaja
TW200602297A (en) Sulfonamide compounds for the treatment of neurodegenerative disorders
WO2008102888A1 (ja) 新規擬似糖脂質及びその用途
EP2063710A4 (en) DIFLUORATED PIPERIDINES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS